75 related articles for article (PubMed ID: 20005198)
1. Amphipathic peptides can act as an anticoagulant by competing with phospholipid membranes for blood coagulation factors.
Charbonneau S; Peng HT; Shek PN; Blostein MD
Biochem Biophys Res Commun; 2010 Jan; 391(2):1197-202. PubMed ID: 20005198
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an ideal amphipathic peptide as a procoagulant agent.
Ganopolsky JG; Charbonneau S; Peng HT; Shek PN; Blostein MD
Biochem J; 2008 Jun; 412(3):545-51. PubMed ID: 18336367
[TBL] [Abstract][Full Text] [Related]
3. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
Alving BM; Barr CF; Johansen LE; Tang DB
Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408
[TBL] [Abstract][Full Text] [Related]
4. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
Brandt JT; Triplett DA
Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
[TBL] [Abstract][Full Text] [Related]
5. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
6. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids.
Rauch J; Tannenbaum M; Janoff AS
Thromb Haemost; 1989 Nov; 62(3):892-6. PubMed ID: 2512678
[TBL] [Abstract][Full Text] [Related]
8. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
[TBL] [Abstract][Full Text] [Related]
9. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
Alving BM; Baldwin PE; Richards RL; Jackson BJ
Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
[TBL] [Abstract][Full Text] [Related]
10. A non-immunological phospholipid-dependent coagulation inhibitor associated with IgGlambda-type multiple myeloma.
Takamiya O; Machida S; Okuda M; Nojima J; Koreeda C; Kubara K
Am J Hematol; 2004 Jan; 75(1):34-9. PubMed ID: 14695630
[TBL] [Abstract][Full Text] [Related]
11. Use of phospholipid bilayers and monolayers in binding studies of vitamin K-dependent blood coagulation proteins.
Castellino FJ; Ellison EH
Methods Mol Biol; 2002; 199():233-43. PubMed ID: 12094573
[No Abstract] [Full Text] [Related]
12. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
[TBL] [Abstract][Full Text] [Related]
13. [The effects of various anticoagulants on blood coagulation: with special reference to false positive lupus anticoagulants].
Onda H; Watanabe H
Rinsho Byori; 1989 Dec; 37(12):1385-91. PubMed ID: 2515325
[TBL] [Abstract][Full Text] [Related]
14. Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors.
Stenflo J
Crit Rev Eukaryot Gene Expr; 1999; 9(1):59-88. PubMed ID: 10200912
[TBL] [Abstract][Full Text] [Related]
15. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants.
Lesperance B; David M; Rauch J; Infante-Rivard C; Rivard GE
Thromb Haemost; 1988 Oct; 60(2):217-9. PubMed ID: 3146139
[TBL] [Abstract][Full Text] [Related]
16. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
Kandiah DA; Krilis SA
Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
[TBL] [Abstract][Full Text] [Related]
18. The laboratory diagnosis of lupus anticoagulants.
Lazarchick J; Kizer J
Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
[TBL] [Abstract][Full Text] [Related]
19. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
20. Screening for the lupus anticoagulant.
Triplett DA
Ric Clin Lab; 1989; 19(4):379-89. PubMed ID: 2517352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
